The impact of diagnosis on the therapeutic management of chronic lymphocytic leukemia


https://doi.org/10.4081/hmr.v3i3.579
Vol. 3 No. 3: 7th Meeting New Insights in Hematology Venice, Italy, 26-29 April 2009
Published: June 12, 2009
Abstract Views: 174
PDF: 208
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The considerable progress in diagnostic tools, the identification of a number of biological markers improving outcome prediction, and the introduction of new treatment strategies have made the therapeutic management of chronic lymphocytic leukemia (CLL) no longer straightforward. Furthermore, the care of individual patients with CLL has become more demanding, and a comprehensive approach to them should include attention to quality of life (QOL) issues, adherence to supportive care guidelines, consideration of age and comorbidity, recognition of clinical complications such as infection, autoimmune cytopenias, and transformation into a more aggressive disease.1 In CLL patients, a risk-stratified approach to therapy based on novel prognostic markers is recommended in the context of clinical trials, but not in general routine. 2 How the novel markers could at least complement the traditional prognostic factors in the clinical management of patients with CLL is now discussed.3

Supporting Agencies


Liso, V., & Rizzi, R. (2009). The impact of diagnosis on the therapeutic management of chronic lymphocytic leukemia. Hematology Meeting Reports (formerly Haematologica Reports), 3(3). https://doi.org/10.4081/hmr.v3i3.579
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC